Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas F Muir

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Cardiology|September 9, 2021
Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe-Rationale and design of the international BENCHMARK registryGemma McCalmont, Eric Durand, Sandra Lauck, et al.
Coronary Artery Disease|June 27, 2018
Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomesMatthew W P Jackson, David Austin, Neil Swanson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 8, 2019
Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center ExperienceMatthew Jackson, Sarah Callaghan, John Stapleton, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 20, 2019
Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trialMarco Barbanti, Martijn S van Mourik, Mark S Spence, et al.
BMC Cardiovascular Disorders|October 12, 2017
Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registryMarco Barbanti, Jan Baan, Mark S Spence, et al.
Interventional Cardiology (London, England)|March 14, 2025
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention SocietyNick Curzen, Helen Routledge, Samuel McGrath, et al.
Journal of the American Heart Association|July 28, 2020
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve ImplantationMark S Spence, Jan Baan, Fortunato Iacovelli, et al.
International Journal of Cardiology|April 6, 2020
Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysisAung Myat, Olympia Papachristofi, Uday Trivedi, et al.
JACC. Cardiovascular Interventions|March 25, 2022
Same-Day Discharge Post-Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic: The Multicenter PROTECT TAVR StudyMadeleine Barker, Janarthanan Sathananthan, Emily Perdoncin, et al.
JAMA|January 9, 2019
Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical TrialPeter J McCartney, Hany Eteiba, Annette M Maznyczka, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Cardiology|September 9, 2021
Setting a benchmark for resource utilization and quality of care in patients undergoing transcatheter aortic valve implantation in Europe-Rationale and design of the international BENCHMARK registryGemma McCalmont, Eric Durand, Sandra Lauck, et al.
Coronary Artery Disease|June 27, 2018
Outcomes after culprit-only percutaneous coronary intervention for multivessel disease during ST-segment elevation myocardial infarction: a comparison of registry and clinical trial outcomesMatthew W P Jackson, David Austin, Neil Swanson, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|January 8, 2019
Rapid Aspirin Desensitization is Safe and Feasible in Patients With Stable and Unstable Coronary Artery Disease: A Single-Center ExperienceMatthew Jackson, Sarah Callaghan, John Stapleton, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 20, 2019
Optimising patient discharge management after transfemoral transcatheter aortic valve implantation: the multicentre European FAST-TAVI trialMarco Barbanti, Martijn S van Mourik, Mark S Spence, et al.
BMC Cardiovascular Disorders|October 12, 2017
Feasibility and safety of early discharge after transfemoral transcatheter aortic valve implantation - rationale and design of the FAST-TAVI registryMarco Barbanti, Jan Baan, Mark S Spence, et al.
Interventional Cardiology (London, England)|March 14, 2025
Percutaneous Coronary Intervention in the UK: Recommendations of the British Cardiovascular Intervention SocietyNick Curzen, Helen Routledge, Samuel McGrath, et al.
Journal of the American Heart Association|July 28, 2020
Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve ImplantationMark S Spence, Jan Baan, Fortunato Iacovelli, et al.
International Journal of Cardiology|April 6, 2020
Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysisAung Myat, Olympia Papachristofi, Uday Trivedi, et al.
JACC. Cardiovascular Interventions|March 25, 2022
Same-Day Discharge Post-Transcatheter Aortic Valve Replacement During the COVID-19 Pandemic: The Multicenter PROTECT TAVR StudyMadeleine Barker, Janarthanan Sathananthan, Emily Perdoncin, et al.
JAMA|January 9, 2019
Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical TrialPeter J McCartney, Hany Eteiba, Annette M Maznyczka, et al.
Pageof 3